WebJul 8, 2024 · Underuse—the failure to deliver a health service that is highly likely to improve the quality or quantity of life, which is affordable, and that the patient would have wanted—is responsible for considerable avoidable morbidity and mortality. For example, WHO estimated 1 that in 2015, 1·5 million children died of vaccine-preventable illnesses. WebJan 1, 2009 · For example, lower-income patients may be more fatalistic about ... each 1-point increase in Concerns was associated with a 2.6 times increase in risk of cost-related antihypertensive medication underuse and with a 1.9 times increase in risk of ... Horne R: Adherence to medication in bipolar disorder: a qualitative study exploring the role of ...
Determinants of medication underuse and medication …
WebFeb 24, 2024 · Identify patient populations that need help. For example, practitioners and health departments can. Map populations with high medication nonadherence rates. Measure medication adherence in a population with high blood pressure. The proportion of days covered (PDC) is the leading method used to calculate medication adherence at … WebMedication non-adherence is a frequent problem in chronic conditions. In patients with chronic non-malignant pain, medication non-adherence ranges between 8% and 53%. Two types of non-adherence can be identified: underuse and overuse of pain medication. hemofil m fda label
Promoting rational use of medicines - WHO
WebIn sum, poor medication adherence takes the lives of 125,000 Americans annually, and costs the health care system nearly $300 billion a year in additional doctor visits, … WebApr 12, 2024 · Good medication adherence involves taking prescribed medications according to the instructions of a healthcare professional. In many cases, this means taking at least 80% of prescribed doses. More ... WebDec 3, 2024 · Abstract. Introduction. Prescription costs are rising, and many patients with chronic illnesses have difficulty paying for prescriptions. Missing or delaying medication because of financial concerns is … hemofil m administration